Lorbrena, like Pfizer's Xalkori, is designed to treat cancer with a mutation of a specific gene called anaplastic ... China's ...
The U.S. Food and Drug Administration (FDA) on Friday approved two gene therapies for sickle cell disease, including one that is the first treatment in the United States based on the Nobel ...
This summary covers recent health news highlights, including Gilead's Trodelvy failing in a bladder cancer trial, Pfizer's ...